Collectively, these data suggest replacement of a corrective CFTR gene to CF ciliated cells is the only manipulation required for correction of the CF defect since both CF and non-CF HAE regulate CFTR activity similarly. The gene discussed is CFTR; the disease is cystic fibrosis.